Loading clinical trials...
Loading clinical trials...
This open-label study aims to evaluate the safety and efficacy of umbilical cord blood therapy for children with global developmental delay.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
MinYoung Kim, M.D.
NCT07369960 · Developmental Delay Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS), and more
NCT05879952 · Global Developmental Delay
NCT04816175 · Microcephaly, Hyperkinesis With Developmental Delay, and more
NCT05398900 · Developmental Delay, Child Development, and more
NCT03847402 · Brain Developmental Diseases, Autism Spectrum Disorder, and more
CHA Bundang Medical Center, CHA University
Seongnam-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions